Wen Bo Wang
Chief Tech/Sci/R&D Officer chez FATE THERAPEUTICS, INC.
Profil
Actuellement, Wen Bo Wang occupe le poste de vice-président principal des opérations techniques chez Fate Therapeutics, Inc. Le Dr Wang est également membre du conseil d'administration de l'organisme de coordination des normes. Auparavant, il a occupé le poste de directeur scientifique associé chez ViaCell, Inc. et celui de premier vice-président de la thérapie cellulaire chez FUJIFILM Cellular Dynamics, Inc. Le Dr Wang a obtenu un diplôme de premier cycle à l'Université océanique de Chine et un doctorat à l'Université de Newcastle.
Postes actifs de Wen Bo Wang
| Sociétés | Poste | Début |
|---|---|---|
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 08/10/2018 |
| Standards Coordinating Body | Director/Board Member | - |
Anciens postes connus de Wen Bo Wang
| Sociétés | Poste | Fin |
|---|---|---|
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2005 |
| CELLULAR DYNAMICS INTERNATIONAL INC | Corporate Officer/Principal | - |
Formation de Wen Bo Wang
| Newcastle University | Doctorate Degree |
| Ocean University of China | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
FUJIFILM Cellular Dynamics, Inc.
 FUJIFILM Cellular Dynamics, Inc. BiotechnologyHealth Technology FUJIFILM Cellular Dynamics, Inc. engages in the provision of human cells used in drug discovery, toxicity testing, stem cell banking, and cell therapy development. It offers cardiac cells, neural cells. hematopoietic and other, and iPSC, services and reagents. The company was founded by James A. Thomson, Igor Slukvin, Timothy J. Kamp and Craig T. January in 2004 and is headquartered in Madison, WI. | Health Technology |
| Standards Coordinating Body |
